To examine current status and quality of CVD related apps available for download in China, a total of 151 apps from the top popular six app stores were analyzed. Data analysis uncovered a range of issues including missing of key variables in the pre-formatted daily records, no platform for interaction with relevant healthcare professionals and undesirable user-interface design. More importantly, these apps had low levels of adherence to internationally recognized guidelines in CVD management. Overall quality score of these apps was below the average (8.08/20). This study identified areas for improvement concerning the existing CVD related apps. Information may guide the further advancement of CVD related apps and benefit CVD management in China.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Improving access to cardiovascular care for 1.4 billion people in China using telehealth.
NPJ Digit Med
December 2024
Lead Medical, Bldg. 6, Fengchuang Science Park, Beijing Economic and Technological Development Zone, Daxing District, Beijing, 101111, China.
Cardiovascular diseases (CVDs) pose a significant health burden in China, where the large population and vast geography limit access to care. Telehealth (tHealth) services provide a virtual model of care that can enhance CVD management. This study aims to describe the trajectory of tHealth services for cardiovascular care between 2016 and 2020 in China, assess their utilization, and discuss their implications for improving access to care in resource-scarce regions.
View Article and Find Full Text PDFPerceptions of healthcare professionals and patients with cardiovascular diseases on mHealth lifestyle apps: A qualitative study.
Int J Med Inform
February 2025
Institute for Physical Activity and Nutrition, Deakin University, Melbourne, Australia.
Background: Cardiovascular disease (CVD) is the leading cause of death globally and is predominantly associated with a cluster of lifestyle risk factors. Mobile health (mHealth) apps offer the potential to overcome traditional barriers by supporting healthy lifestyle behaviours. However, knowledge about perceptions of mHealth lifestyle apps among healthcare professionals and people with CVD is sparse.
View Article and Find Full Text PDFThe Role of Visualization in Estimating Cardiovascular Disease Risk: Scoping Review.
JMIR Public Health Surveill
October 2024
Faculty of Health Sciences, University of Maribor, Maribor, Slovenia.
Article Synopsis
- * The objective is to identify and evaluate the most commonly used visualization techniques for estimating CVD risk through a systematic review of existing literature.
- * After screening 774 articles, 17 relevant studies were included, showcasing a variety of methods for estimating CVD risk, ranging from simple models that don't require lab tests to more complex recommendations by health organizations.
The Influence of Physical Activity and Diet Mobile Apps on Cardiovascular Disease Risk Factors: Meta-Review.
J Med Internet Res
October 2024
University of Connecticut, Storrs, CT, United States.
Background: The literature on whether physical activity (PA) and PA and diet (PA+Diet) mobile apps improve cardiovascular disease (CVD) risk factors is promising.
Objective: The aim of this meta-review is to provide an evidence synthesis of systematic reviews and meta-analyses examining the influence of PA and PA+Diet apps on the major CVD risk factors.
Methods: We systematically searched 5 databases until January 12, 2022.
Mobile health apps for cardiovascular risk assessment: a systematic review.
Front Cardiovasc Med
September 2024
CHANGE Research Working Group, Carrera de Medicina Humana, Facultad de Ciencias de la Salud, Universidad Científica del Sur, Lima, Peru.
Introduction: mHealth apps (MHA) are emerging as promising tools for cardiovascular risk assessment, but few meet the standards required for clinical use. We aim to evaluate the quality and functionality of mHealth apps for cardiovascular risk assessment by healthcare professionals.
Methods: We conducted a systematic review of MHA for cardiovascular risk assessment in the Apple Store, Play Store, and Microsoft Store until August 2023.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!